94136-64-8

Basic information

• Product Name: Carbamic acid, [6-oxo-6-[(phenylmethoxy)amino]hexyl]-, 1,1-dimethylethyl ester
• CAS NO: 94136-64-8
• Molecular Formula: C18H28N2O4
• Molecular Weight: 336.431
• Mol File: 94136-64-8.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: Carbamic acid, [6-oxo-6-[(phenylmethoxy)amino]hexyl]-, 1,1-dimethylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, [6-oxo-6-[(phenylmethoxy)amino]hexyl]-, 1,1-dimethylethyl ester(94136-64-8)
• EPA Substance Registry System: Carbamic acid, [6-oxo-6-[(phenylmethoxy)amino]hexyl]-, 1,1-dimethylethyl ester(94136-64-8)

Safety Data

• Hazardous Substances Data: 94136-64-8(Hazardous Substances Data)

Upstream product

• 6404-29-1 6-(tert-butoxycarbonylamino)hexanoic acid 
• 2687-43-6 O-benzylhydoxylamine hydrochloride 
• 24424-99-5 di-tert-butyl dicarbonate 
• 60-32-2 6-aminohexanoic acid 
• 106412-36-6 tert-butyl 2-oxoazepane-1-carboxylate 

Downstream Products

• 251304-84-4 6-N-(4-dimethylaminophenylcarbamoyl)hexanoic acid N'-benzoyloxyamide 
• 94136-67-1 N,N',N''-tris<5-<(benzyloxy)methylcarbamoyl>pentyl>tricarballylamide 
• 94136-66-0 6-Amino-hexanoic acid benzyloxy-methyl-amide 
• 71925-14-9 O-benzyl-N-methylhydroxylamine hydrochloride 
• 94136-65-9 benzyl N-methyl-6-<(tert-butoxycarbonyl)amino>caprohydroxamate 

Relevant articles and documents

MDM2-HDAC double-target inhibitor, medicinal composition and preparation and application of MDM2-HDAC double-target inhibitor

The invention provides a MDM2-HDAC double-target inhibitor, a medicinal composition and preparation and application of the MDM2-HDAC double-target inhibitor. The MDM2-HDAC double-target inhibitor hasa structure as shown in formula I. The inhibitor with th

HDAC INHIBITORS

The present invention provides hydroxamic acid compounds, and methods of preparation of these compounds. The present invention also relates to pharmaceutical compositions comprising the hydroxamic acid compounds. The present invention provides methods of treating a cell proliferative disorder, such as a cancer, by administering to a subject in need thereof a therapeutically effective amount of a compound of the present invention.

An easy and convenient synthesis of Weinreb amides and hydroxamates

-